The misconceptions surrounding ADHD often provoke questions from uninformed people that can hurt the feelings of those with ...

Children younger than 6 years of age who are prescribed extended-release stimulants for attention-deficit hyperactivity disorder (ADHD) may experience ...

A Cambridge biotech company is preparing to lay off its entire staff of more than 300 after being acquired by another firm.

The FDA now requires updated labeling for all extended-release stimulant medications used to treat attention deficit hyperactivity disorder, warning of increased risk of weight loss and other side ...

Actress and talk show host Busy Philipps as well as sports reporter Jay Glazer have both headed up separate campaigns for Qelbree, a non-stimulant ADHD treatment manufactured by Supernus. This marks a ...

The latest "Adult Psychiatric Morbidity Survey" (APMS), published by NHS England, shows a sharp rise in mental health issues ...

The US Food and Drug Administration (FDA) is revising the labeling of all extended-release stimulants indicated to treat attention-deficit/hyperactivity disorder (ADHD)—including certain formulations ...

In Australia, psychiatrists prescribe ADHD medication. For more details, reach out to the ADHD Foundation Australia. The PBS ...

Altogether, 1.75 million people in England received the higher level of PIP in April 2025 - an increase from 734,136 in ...

Telehealth prescribing of stimulants for teens and adults with ADHD is not linked to a higher risk for substance use disorder vs in-person prescribing, a new study shows.

Scientists and public health advocates see disconnects between what the Trump administration says about health — notably, in ...

The diagnostic category of adult ADHD is becoming more inclusive. That’s not the same as it being overdiagnosed ...